CORT
CORT
NASDAQ · Pharmaceuticals

Corcept Therapeutics Inc

Mid-Cap Stocks Pharmaceutical Stocks Healthcare Stocks
$33.82
+0.19 (+0.57%)
As of Mar 24, 9:55 PM ET ·
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Buy 9 75%
Hold 2 17%
Sell 1 8%
Price Target
Analyst Price Target +202.6% upside
Low Target $62.31
Average Target $102.33
High Target $121.34
Current Price $33.82
Current
$33.82
Target
$102.33
$62.31 $102.33 avg $121.34
Scenario Analysis
Bear Case
$62.31
84.2%
Low target
Base Case
$102.33
+202.6%
Avg target
Bull Case
$121.34
+258.8%
High target
Risk/Reward
3.1x
Highly favorable
Price in Context
52-Week High
$117.33
-71.2% from high
52-Week Low
$28.66
+18.0% from low
50-Day SMA
$53.13
-36.3% vs SMA
200-Day SMA
$69.00
-51.0% vs SMA
RSI (14)
26.0
Oversold
Target vs 52W High
$102.33
-12.8% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
 Strong Buy 39 77% $1,330.33 +47.3%
JNJ
Johnson & Johnson
 Buy 32 59% $299.55 +27.3%
MRK
Merck & Co. Inc.
 Buy 36 67% $159.27 +36.9%
PFE
Pfizer Inc.
 Hold 35 40% $33.90 +25.7%
BMY
Bristol-Myers Squibb Co
 Hold 36 42% $174.50 +204.1%
ZTS
Zoetis Inc
 Buy 25 64% $209.87 +81.0%
RPRX
Royalty Pharma Plc- Cl A
 Strong Buy 16 88% $36.26 -20.4%
VTRS
Viatris Inc
 Buy 18 67% $122.82 +819.3%